PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor Overactivity
2019 ◽
Vol 201
(1)
◽
pp. 174-181
◽
2009 ◽
Vol 41
(4)
◽
pp. 805-813
◽
2010 ◽
Vol 9
(2)
◽
pp. 60-61
◽
2005 ◽
Vol 86
(11)
◽
pp. 2114-2118
◽
2009 ◽
Vol 5
(6)
◽
pp. 430-436
◽